member login

Welcome to VacTrain
An initial training network for vaccinologists

 


Vaccination

Vaccines are among the most cost-effective health interventions ever developed; they save millions of live each year. Immunization has led to the eradication of smallpox and the near-eradication of polio. Immunization also contributes to broader economic benefits and increased cognitive abilities (Deogaonkar et al., 2012; Ozawa et al., 2012).

 

Vaccinology is the multidisciplinary discipline of developing vaccine interventions and combines knowledge from basic sciences, medical sciences, public health and social sciences. Ideally a vaccinologist should have a general overview of all disciplines involved and at the same time be able to zoom in on her/his own discipline. There is a need to train young scientists as vaccinologists to create a continuous pipeline of vaccinologists for the future (Poland et al., 2010). There is also a clear need for innovation in vaccine development. The expectation is that systems biology and other technological advances will speed up vaccine development (Koff et al., 2012).
 

VacTrain is a Marie Curie Initial Training Network funded by the 7th Framework People Programme of the European Commission. Eleven PhD students (VacTrainees) will be trained  to become the next generation of vaccinologists. They will work in leading European research groups in academia and industry, located in the Netherlands, United Kingdom, Belgium, Israel, Germany, Italy and Austria. In addition, VacTrain includes four European associated partners and a Research Training and Advisory committee consisting of five top scientists in the field of vaccinology.
 

The main objectives of VacTrain are:

Camel carrying vaccines

 
• To provide talented Early Stage Researchers (ESRs) a state-of-the-art multidisciplinary and intersectional training in vaccinology leading to a PhD degree.

• To improve the career perspectives of its ESRs by broad and complementary skill development (e.g. management, innovation, communication, writing, dissemination, intellectual property, valorisation and entrepreneurship).

• To answer the most urgent questions in vaccine development and apply them to develop candidate vaccines with the highest possible impact.

• To contribute to a lasting pan-European multidisciplinary and intersectional network with key players in vaccinology from the academia and the private sector in Europe that will have considerable impact on the field of vaccinology.


Contact us: vactrain@lumc.nl

 

Find our blog: News from the Vaccine World

 

Funded by the EU under the FP7 Marie Curie Action - Grant number: 316655
website built by Guus Wolswijk